Evidence map›Paper›PMID 17112319›Full record

ArticlePLoS genetics2006

Functional identification of Api5 as a suppressor of E2F-dependent apoptosis in vivo.

Erick J Morris, William A Michaud, Jun-Yuan Ji, Nam-Sung Moon, James W Rocco, Nicholas J Dyson

Open access · goldAbstract read
In one paragraph

Article in PLoS genetics, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 66 papers.

0numbers the graph read from it
0cells of the map it votes in
66citing papers in PubMed
4.6field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

66 citing papers in PubMed, 126 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

6 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Erick J MorrisMassachusetts General Hospital Cancer Center, Laboratory of Molecular Oncology, Charlestown, Massachusetts, United States of America.
William A Michaud
Jun-Yuan Ji
Nam-Sung Moon
James W Rocco
Nicholas J Dyson
Harvard University · USMassachusetts Eye and Ear Infirmary · US

Funding

Screen for genes targeted by homozygous deletion during cancer progressionP01CA095281 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI HABER, DANIEL A. · 2002 to 2006
$8.4M
The E2F/RBF networkR01GM053203 · NIGMS · MASSACHUSETTS GENERAL HOSPITAL · PI DYSON, NICHOLAS J · 1995 to 2010
$4.2M
Regulation of Rbf and dE2F in Drosophila melanogasterF32CA088474 · NCI · MASSACHUSETTS GENERAL HOSPITAL · PI MORRIS, ERICK J · 2001 to 2003
$148k
NCI NIH HHS F32 CA088474NCI NIH HHS F32CA88474NCI NIH HHS P01 CA095281NCI NIH HHS P01CA095281NIGMS NIH HHS GM53203NIGMS NIH HHS R01 GM053203
6 · The paper itself

Abstract

Retinoblastoma protein and E2-promoter binding factor (E2F) family members are important regulators of G1-S phase progression. Deregulated E2F also sensitizes cells to apoptosis, but this aspect of E2F function is poorly understood. Studies of E2F-induced apoptosis have mostly been carried out in tissue culture cells, and the analysis of the factors that are important for this process has been restricted to the testing of a few candidate genes. Using Drosophila as a model system, we have generated tools that allow genetic modifiers of E2F-dependent apoptosis to be identified in vivo and developed assays that allow effects on E2F-induced apoptosis to be studied in cultured cells. Genetic interactions show that dE2F1-dependent apoptosis in vivo involves dArk/Apaf1 apoptosome-dependent activation of both initiator and effector caspases and is sensitive to levels of Drosophila inhibitor of apoptosis-1 (dIAP1). Using these approaches, we report the surprising finding that apoptosis inhibitor-5/antiapoptosis clone-11 (Api5/Aac11) is a critical determinant of dE2F1-induced apoptosis in vivo and in vitro. This functional interaction occurs in multiple tissues, is specific to E2F-induced apoptosis, and is conserved from flies to humans. Interestingly, Api5/Aac11 acts downstream of E2F and suppresses E2F-dependent apoptosis without generally blocking E2F-dependent transcription. Api5/Aac11 expression is often upregulated in tumor cells, particularly in metastatic cells. We find that depletion of Api5 is tumor cell lethal. The strong genetic interaction between E2F and Api5/Aac11 suggests that elevated levels of Api5 may be selected during tumorigenesis to allow cells with deregulated E2F activity to survive under suboptimal conditions. Therefore, inhibition of Api5 function might offer a possible mechanism for antitumor exploitation.

Indexed as

ApoptosisSuppression, GeneticAmino Acid SequenceAnimalsApoptosis Regulatory ProteinsCyclin-Dependent Kinase Inhibitor p16Drosophila melanogasterDrosophila ProteinsE2F1 Transcription FactorHumansMolecular Sequence DataNuclear ProteinsPhenotypeRetinoblastoma ProteinRNA InterferenceTranscription FactorsAPI5 protein, humanApoptosis Regulatory ProteinsCyclin-Dependent Kinase Inhibitor p16Drosophila ProteinsE2F1 Transcription FactorNuclear ProteinsRbf protein, DrosophilaRetinoblastoma ProteinTranscription Factors

Identifiers

PMID17112319
PMCPMC1636698
OpenAlexW2099110757

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.